SummitTX Capital’s Labcorp LH Stock Holding History

SummitTX Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,448	Closed	-$380K	–	882
2025 Q2	$380K	Buy	+1,448	New	+$353K	0.02%	560

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

SummitTX Capital's LH Position: Q3 2025 in Review

SummitTX Capital sold out of Labcorp (LH) in Q3 2025, closing a stake of 1,448 shares — an estimated $380K sold.

SummitTX Capital first reported a position in LH in Q2 2025 and held it in 1 quarter. The position peaked at $380K in Q2 2025. 1,012 funds tracked by Wall St. Rank hold LH as of Q3 2025.

SummitTX Capital reported no remaining Labcorp position as of Q3 2025 after selling out during the quarter.
SummitTX Capital sold 1,448 Labcorp shares in Q3 2025, an estimated $380K.
SummitTX Capital first reported a position in Labcorp in Q2 2025 and held it in 1 quarter.
SummitTX Capital's Labcorp position peaked at $380K in Q2 2025.
1,012 funds tracked by Wall St. Rank held Labcorp as of Q3 2025.

Based on SummitTX Capital's 13F filing for Q3 2025, filed 14 Nov 2025.